Direct-to-consumer advertising: a modifiable driver of overdiagnosis and overtreatment.

BMJ Evid Based Med

School of Health Policy and Management, York University, Toronto, Ontario, Canada.

Published: November 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjebm-2023-112622DOI Listing

Publication Analysis

Top Keywords

direct-to-consumer advertising
4
advertising modifiable
4
modifiable driver
4
driver overdiagnosis
4
overdiagnosis overtreatment
4
direct-to-consumer
1
modifiable
1
driver
1
overdiagnosis
1
overtreatment
1

Similar Publications

Introduction: Some manufacturers of electronic nicotine delivery systems (ENDS) and liquids sell products with flavor names that use ambiguous terminology rather than explicitly characterize the product's flavor. These are often referred to as 'concept flavors'. This article presents a sample of ENDS concept flavor names to identify naming conventions the industry uses.

View Article and Find Full Text PDF

Background: Direct-to-consumer advertising (DTCA) in cancer care influences patient decisions but often targets vulnerable populations. Despite established ethical guidelines, adherence remains understudied. This study evaluates how well top U.

View Article and Find Full Text PDF

Background: Medical providers started to consider Transcranial Magnetic Stimulation (TMS) for the noninvasive treatment of different psychiatric and neurology disorders as this technique become more popular in recent years. Many medical providers are trying to reach patients using direct-to-consumer (DTC) promotion of approved and off-label indications. Most of the time, these ads exaggerate benefits, create unrealistic expectations, and often exaggerate benefits.

View Article and Find Full Text PDF